Skin Cancer and Dermatology Service
Overview
Summary, notice description and lot information
The NHS Greater Manchester Integrated Care Board (NHS GM ICB) is in the process of awarding a contract for Skin Cancer and Dermatology Services within the health services sector (CPV: 85100000). The contract period is from 1st April 2024 to 31st March 2025, with a total value of £6,036. The procurement method utilised is a Provider Selection Regime (PSR) Direct Award Process C, and the award is currently in the intention to award stage.
Key dates include the standstill period ending at midnight on 22nd March 2025, during which representations can be made by providers. The services are to be delivered within the UKD region. The tender for Skin Cancer and Dermatology Services presents substantial opportunities for growth within the health services industry, particularly for providers specialising in skin care and dermatology.
Businesses focused on quality and innovation, value, integration, collaboration, service sustainability, access improvement, reducing health inequalities, facilitating choice, and social value will be highly competitive. Manor House Surgery has already been identified as the intended supplier. Organisations with a strong foothold in the specified criteria and those looking to expand their reach in public health services should consider engaging with NHS GM ICB during the standstill period to discuss potential opportunities.
Skin Cancer and Dermatology Services to be delivered to NHS GM ICB. This contract will be for 12-months from 1st April 2024 to 31st March 2025. The total value of this contract is PS6,036.
This is a Provider Selection Regime (PSR) Direct Award Process C intention to award notice.
The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of The Procurement Act 2023 Regulations do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by midnight on 22nd March 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. Written representations should be sent to: nhsgm.procurement@nhs.net Key Award Criteria - Quality and Innovation - 20%, Value - 20%, Integration, collaboration and service sustainability - 20%. Improving access, reducing health inequalities and facilitating choice - 20%, Social Value - 20%. Award decision-makers: Corporate Director of Finance - Commissioning & Financial Assurance and the Executive Committee on behalf on NHS Greater Manchester Integrated Care Board. No conflicts of interest were declared.
Procurement Classification
Notice type, method, and CPV codes
Contract Values
Financial information and value estimates
Contract duration information not available.
Key Dates
Publication, submission, and award timeline
Notice Status
Current status of tender, lots, awards, and contracts
Contracting Authority
Buyer organisation and contact details
Awarded Supplier
Supplier who was awarded this contract
Documents & Links
External resources and data downloads
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector.
Need help with your tender submission?
Our expert team can help you prepare a winning bid. Get professional support from CareSync Experts.
Get in touch with our team at Care Sync Experts today for a consultation.
Email: hello@caresyncexperts.co.uk
Phone: 0333 577 0877
Contact UsBidding for contracts like this
Other tenders in Not specified
- NHS2305 - Haematology and Oncology Supportive Services in Not specified
- NHS2248- Histopathology Service Outsourced 24-25 in Not specified
- Mpox post exposure vaccine in Not specified
- Emergency Hotels Services in Not specified
- Primary Mental Health Treatment Requirements (MHTR) in Not specified
- FSA Delivered Official Controls in England and Wales variation 29 in Not specified